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Abstract
Objective—A highly polygenic etiology and high degree of allele-sharing between ancestries
have been well-elucidated in genetic studies of rheumatoid arthritis. Recently, the high-density
genotyping array Immunochip for immune disease loci identified 14 new rheumatoid arthritis risk
loci among individuals of European ancestry. Here, we aimed to identify new rheumatoid arthritis
risk loci using Korean-specific Immunochip data.
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Methods—We analyzed Korean rheumatoid arthritis case-control samples using the Immunochip
and GWAS array to search for new risk alleles of rheumatoid arthritis with anti-citrullinated
peptide antibodies. To increase power, we performed a meta-analysis of Korean data with
previously published European Immunochip and GWAS data, for a total sample size of 9,299
Korean and 45,790 European case-control samples.
Results—We identified 8 new rheumatoid arthritis susceptibility loci (TNFSF4, LBH, EOMES,
ETS1–FLI1, COG6, RAD51B, UBASH3A and SYNGR1) that passed a genome-wide significance
threshold (p<5×10−8), with evidence for three independent risk alleles at 1q25/TNFSF4. The risk
alleles from the 7 new loci except for the TNFSF4 locus (monomorphic in Koreans), together with
risk alleles from previously established RA risk loci, exhibited a high correlation of effect sizes
between ancestries. Further, we refined the number of SNPs that represent potentially causal
variants through a trans-ethnic comparison of densely genotyped SNPs.

Author Manuscript

Conclusion—This study demonstrates the advantage of dense-mapping and trans-ancestral
analysis for identification of potentially causal SNPs. In addition, our findings support the
importance of T cells in the pathogenesis and the fact of frequent overlap of risk loci among
diverse autoimmune diseases.
Keywords
Rheumatoid arthritis; Gene polymorphism; Anti-CCP

Introduction

Author Manuscript

Rheumatoid arthritis (RA; OMIM180300) is a chronic and systemic autoimmune disease
affecting up to 1% of the adult population worldwide.1 Total heritability of RA was
estimated to be ~65% from a previous twin study that compared the disease discordance in
monozygotic twins with dizygotic twins.2 To date, >50 risk loci have been discovered
among individuals of European and Asian ancestry,3,4 but only ~16% of the heritability (or
~25% of the genetic heritability) could be explained by the confirmed risk loci.5 Current RA
genetic studies have revealed a highly polygenic etiology by an inferred genetic architecture
that hundreds (if not thousands) of common SNPs with modest effect and smaller number of
rare causal variants account for total genetic heritability of RA.6

Author Manuscript

A previous study reported the majority of the RA susceptibility alleles are shared among
individuals of European and Japanese ancestry (correlation coefficient for effect sizes
between ancestries=0.82).3 This observation suggests that there are shared causal variants
between the two populations, and further suggests that a large cohort study using multiple
ancestries can be powerful to detect new RA risk loci.7
Recently, 14 new RA risk loci were identified by integrating high-density genotype data of
immune loci from the Immunochip (iChip) and imputed data from genome-wide association
studies (GWAS) among individuals of European ancestry.4 Here, we generate a new iChip +
GWAS dataset among individuals of Korean ancestry. We perform a meta-analysis with a
previously published European iChip + GWAS dataset,4 as well as new iChip data from
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individuals of European ancestry (n=2,840), for a total sample size of 9,299 Korean and
45,790 European case-control samples (online supplementary table S1).

METHODS
Korean Subjects, Genotyping, Imputation and Quality Control

Author Manuscript

A total of 4,689 subjects including 1,525 RA cases [average age=52.7 (17–82);
female=83.4%] with anti-citrullinated peptide antibodies (ACPA) and 3,164 healthy controls
[average age=39.4 (16–79); female=60.7%] were genotyped by the customized iChip array
at multiple centers (SNP Genetics, Inc. Korea and Feinstein Institute for Medical Research
for BAE#1; Oklahoma Medical Research Foundation for BAE#2; University of Queensland
Diamantina Institute for BAE#3) (online supplementary table S1). Each sub-collection was
filtered using standard criteria based on minor allele frequency (MAF), Hardy-Weinberg
equilibrium (HWE), call rate per SNP, call rate per individual, unique mapping, genetic
homogeneity, population stratification, and cryptic relatedness (duplicate and cryptic 1st
degree relative) before and/or after merging the sub-collections (online supplementary table
S2).
An independent set of 3,700 Korean controls [average age = 59.8 (38–89); female = 63.0%]
was examined by Illumina HumanOmni1-Quad BeadChip GWAS array at Korea National
Institute of Health. A sample was removed if it showed low call rate (<0.95), heterozygosity
<0.26 or >0.30, cryptic relatedness (cryptic 1st degree relative) or sex inconsistency. The
genotype data was merged with a previously reported Korean RA GWAS dataset of 709
ACPA-positive RA cases [average age=52.4 (19–82); female=89.7%] and 201 controls
[average age=39.8 (17–76); female=74.6%].8
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After merging the GWAS datasets, we applied the quality control criteria of MAF≥0.01, p
value of HWE<10−4 and call rate>95% in controls and cases. The quality control-passed
control-case GWAS data were pre-phased to construct haplotypes of the autosomal
chromosomes by SHAPEIT9 and subsequent imputation was performed by IMPUTE210
using the 1000 Genomes Project phase I reference panel. The imputed data was filtered by
the criteria of MAF>1%, Maximum probability≥0.9, p value of HWE<10−4 and Call rate per
SNP≥0.95. A total of 65,014 iChip markers were extracted from the imputed data (online
supplementary table S3).

Author Manuscript

Principal component analysis was performed by the SNP & Variation Suite 7 software using
the SNPs with MAF>5% and linkage disequilibrium (LD) r2<0.2 with other SNPs in a +/
−250kb window. Cryptic relatedness with high kinship coefficient (>0.177) corresponding
to the duplicate or 1st-degree relative was estimated by the KING software.11 Quantilequantile (Q-Q) plots were generated using the SNPs associated with reading and writing
ability to estimate inflation.
In order to examine the third-effect SNP rs2027498 in TNFSF4, an independent Korean
cohort including 1,254 RA cases [average age=53.1 (17–88); female=87.2%;
ACPA(+)=71.1%, ACPA(−)=2.0%, ACPA(not tested)=26.9%] and 1,011 healthy controls
[average age=54.0 (40–86); female=80.0%] was recruited. The genotyping was performed
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using Sequenom iPlex platform at LabGenomics Co. LTD, showing a genotype call rate of
98.1% and no deviation from HWE.
All patients fulfilled the 1987 criteria of the American College of Rheumatology. The level
of ACPA in the Korean RA patients was measured by using the ImmuLisa CCP2 enzymelinked immunosorbent assay kit. Anti-cyclic citrullinated peptide (Anti-CCP) >25 units/ml
was considered as positive for ACPA.
European Subjects, Imputation and quality control

Author Manuscript

The seven European iChip data (ES, NL, SE-E, SE-U, UK, US and i2b2/CORRONA) listed
in supplementary table S1 were reported in two previous studies.4,12 ACPA-negative
samples were additionally removed from all data passing the quality control criteria in the
previous studies. The ACPA-positive iChip data were further filtered for missingness per
SNP/Individual (<0.01), MAF (<0.01) and HWE (p<10−7).
Each European GWAS data (BRASS, CANADA, NARAC2 and WTCCC) independent of
the Immunochip data was pre-phased and imputed by MaCH13 and Minimac14 using the
high-density phased reference data from the 1000 Genome Project instead of the reference
phase of the HapMap2 data used in the previous study.4 The imputed data was filtered to
restrict the analysis to ACPA positive cases and SNPs with MAF≥1% and imputationr2≥0.5. Q-Q plots were generated for each European collection using the SNPs associated
with reading and writing ability. All patients in the reported datasets fulfilled the 1987
criteria of the American College of Rheumatology or were diagnosed by a professional
rheumatologist.
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RA Association Test
odds ratio (OR) and 95% confidence interval (CI) were calculated by PLINK15 with
adjustment for top 5 or 10 PCs in the logistic regression to test whether each autosomal SNP
was associated with susceptibility to RA. A fixed-effects inverse-variance meta-analysis of
the association results from each collection and a heterogeneity test of the SNP effects
among the collections were conducted by the GWAMA software.16 Statistical power to
detect RA association was calculated using the CaTS Power calculator.
Secondary-Effect Analysis

Author Manuscript

The presence of independent effect within the new RA loci with dense iChip markers was
examined by conditioning on a lead SNP and/or other independent-effect SNPs and PCs as
covariates. The conditional analysis using forward stepwise logistic regression for each
collection and subsequent meta-analysis was performed by PLINK15 and GWAMA16,
respectively. When a SNP was significant with p<5×10−5 in the conditional analysis, the
SNP was considered to have independent effect.
The genotypes of the independent-effect SNPs (rs61828284, rs4090392 and rs2027498) in
1q25/TNFSF4 were phased using PLINK15. The haplotypes were examined in the European
collections that were successfully genotyped or imputed for all three SNPs. In Koreans,
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rs61828284 and rs4090392 were too rare to infer the haplotype or to perform statistical
analysis.
Proxy SNP Analysis
The HaploReg v2 software17 was used to search the proxy SNPs of the RA-associated SNPs
and to annotate the functional effects at the SNP position. Association of each SNP in the
novel RA loci with the expression of the genes within the locus was evaluated using
published eQTL data from the lymphoblastoid cell lines of the 856 healthy female twins of
the MuTHER resource18 and the HapMap population19 in the Genevar v3.2.0 web-based
software20.

RESULTS
Author Manuscript

Korean-only Analysis
We first analyzed the Korean iChip + GWAS data from 2,234 cases and 7,065 controls. A
total of 96,952 iChip SNPs passed quality control in the Korean iChip dataset (online
supplementary table S2) and the GWAS-based imputed dataset (online supplementary table
S3 and figure S1). Principal components analysis was used to correct for population
stratification, showing no outliers (online supplementary figure S2). We performed logistic
regression analyses to calculate OR and 95% CI adjusted for the top 10 principal
components in the iChip and GWAS datasets independently, followed by an inversevariance-weighted fixed-model meta-analysis. Q-Q plots of p values and inflation factors
indicated little evidence of systematic bias (λ1000 = 1.010; online supplementary figure S3).
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While we were able to replicate four known RA risk loci (HLA, PADI4, STAT4 and
RASGRP1), no new RA risk loci were identified in the Korean-only analysis at a genomewide level of significance (p<5×10−8; online supplementary figure S4). However, this
analysis was underpowered to achieve the genome-wide significance for alleles with modest
effect (online supplementary figure S5).
Korean-European meta-analysis: Identification of 8 new RA risk loci
Since most known rheumatoid arthritis risk alleles are shared among individuals of
European and Asian ancestry,3 we performed a meta-analysis with recently published iChip
+ GWAS data4 and new iChip data12 derived from case-control samples of European
ancestry. The GWAS data were imputed to iChip markers using 1000 Genome Project data.
A total of 133,816 SNPs were analyzed in the Korean-European meta-analysis (λ1000 =
1.003) (online supplementary figure S1 and S3).

Author Manuscript

In a combined analysis, we found 8 new RA susceptibility loci passing a genome-wide
significance threshold of p<5×10−8 (figure 1). For 7 of the 8 loci, the new signal of
association was driven by adding the Korean data to the previously published European
iChip + GWAS data. One locus on 1q25 (containing the TNFSF4 gene), was identified by
adding new European iChip data to the previously published iChip + GWAS European
dataset (table 1). A Cochran’s Q test with a forest plot for each associated locus indicated no

Ann Rheum Dis. Author manuscript; available in PMC 2015 June 15.

Kim et al.

Page 7

Author Manuscript

obvious evidence of heterogeneity across sample collections (figure 2 and online
supplementary table S4).
The lead SNP at the UBASH3A locus, rs1893592, demonstrated evidence of genetic
heterogeneity among the collections, (pq-test=0.0029). However, this heterogeneity was
derived mainly from single collection of European ancestry (NL), rather than heterogeneity
between Asian and European populations (figure 2).

Author Manuscript

In addition to the novel loci, we confirmed association at 35 known non-HLA loci at
p<5×10−8 (figure 1). Another 12 known RA risk loci included on the iChip array
demonstrated consistent direction of effects at a suggestive level of significance
(5×10−8<p≤1.31×10−3) (online supplementary table S4). The only previously reported RA
risk allele in a Japanese population that did not demonstrate an association in our analysis
(p>0.05) was at the CD244 locus (online supplementary table S4).
The SNP with the strongest signal of association at each of the new and known loci
(excluding the CD244 locus) exhibited a high correlation of effect sizes between
populations, with the same allele conferring RA risk in individuals of Korean and European
ancestry for most loci (correlation coefficient=0.91; online supplementary figure S6). There
were, however, 10 SNPs in which the European risk allele was present at a very low MAF
among individuals of Korean ancestry, as has been observed for the risk allele of PTPN22.21
Three independent risk alleles in 1q25/TNFSF4

Author Manuscript

For the 8 novel loci, we investigated for evidence of independent risk alleles by performing
conditional analysis on the lead SNP in the combined Korean-European sample set. We
found evidence for two additional risk alleles at the 1q25/TNFSF4 locus: both rs4090392
(pcond=3.82×10−7) and rs2027498 (pcond=1.16×10−5) contributed signals independent of the
lead SNP rs61828284 (online supplementary figure S7, S8 and table S5). However, 2 of the
3 1q25/TNFSF4 SNPs were very rare among Koreans (rs61828284 and rs4090392); the
third SNP (rs2027498) was common in Koreans and showed the same direction of effect in
both populations (OREUR=0.90 [0.86–0.94] and ORKOR=0.95 [0.84–1.09]). Among
Europeans, these three SNPs are in weak LD (r2≤0.1, |D'|≤0.66). The TAA haplotype
carrying the three protective alleles exhibited the greatest protection against RA (OR=0.67
[0.57–0.77]; online supplementary figure S9).

Author Manuscript

It was possible that third effect SNP was associated in Koreans as well as Europeans
because the effect size of the SNP was similar between populations. In order to increase
power (52%), we attempted additional genotyping of rs2027498 for an independent set of
1,254 RA cases and 1,011 controls from Korea, but did not find evidence of association
(pmeta=0.87; OR=1.01; online supplementary Table S6).
Identification of potentially causal SNPs by trans-ethnic mapping
To find the most likely causal variants in the 7 new loci with consistent signals of
association in both Koreans and Europeans (excluding 1q25/TNFSF4), we examined local
patterns of LD and annotated putative functional variants. The lead SNPs at these 7 loci
were in LD with 55 and 51 SNPs at r2≥0.9 in the 1000 Genome Project data of East Asian
Ann Rheum Dis. Author manuscript; available in PMC 2015 June 15.
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(CHB+JPT) and European (CEU) ancestry, respectively. Considering the overlap between
the two populations, we observed only 37 SNPs in LD with the lead SNPs in both
populations, none of which was a nonsynonymous, nonsense or splicing-site variant (online
supplementary table S7).
When we applied the trans-ethnic mapping to 21 known RA loci and 7 new RA loci
showing association in meta-analysis (p<5×10−8) and each of populations (p<0.05), we
could narrow down the number of proxy SNPs from 492 SNPs (445 SNPs in Koreans and
231 SNPs in European) to 182 SNPs in the 21 known loci. Among the 28 RA loci, 16 and 19
loci had the decreased number of the proxy SNPs in Koreans and Europeans, respectively
(online supplementary figure S10 and table S8).
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An example of the trans-ethnic mapping approach is shown in figure 3. Only 2 out of 8
SNPs were in LD with the lead SNP in both populations: rs909685 (lead SNP) and
rs2069235 (r2=0.92 in Asian and r2=1.00 in European). This locus contains SYNGR1 (an
integral membrane protein associated with presynaptic vesicles in neuronal cells, which is
also known as a susceptibility locus for primary biliary cirrhosis.22 Both variants lie within
putative functional sequences (e.g., transcriptional factor-binding motif alteration, histone
marks, DNase hypersensitivity, DNA-binding proteins). Furthermore, both SNPs were
identical to the most significant eQTL associated with SYNGR1 expression from
lymphoblastoid cell lines in previous four studies (online supplementary figure
S11).18,19,23,24

DISCUSSION
Author Manuscript

Based on previous Asian-European studies3,25 and theoretical estimates of the polygenic
architecture of RA6, a large number of common genetic variants with modest effect size on
risk of RA are expected to be discovered by a trans-ethnic approach. Here, we identified 8
new loci with relatively modest OR (0.81≤OR≤0.91 and 1.10≤OR≤1.13) using a large
cohort of Korean and European populations, bring the number of RA loci to >60.
There are several important observations from our study. First, the association of the new
loci exhibits a similar trend of ORs between Korean and European populations. Further,
there were similar trends of ORs among the 13 data collections and no remarkable deviation
between observed and reported MAF, which indicates little possibility of systemic bias or
error.

Author Manuscript

Second, our study continues to emphasize the importance of T cell biology in the
pathogenesis of RA.26 Four of the 8 new loci contain genes with established function in
CD4+ T cells. TNFSF4, which encodes a cytokine OX40L in the TNF ligand family, is
involved in the regulation of T cell-mediated immune responses.27 EOMES encodes a
transcription factor with a crucial role in differentiation of CD8+ T cells and homeostasis of
effector and memory T-cells.28 ETS1 encodes a transcription factor that regulates the
differentiation of Th1 cells, regulatory T cells and B cells by affecting the function of other
key regulators like T-bet, Foxp3 and Blimp-1.29 UBASH3A encodes a T-cell ubiquitin ligand
that acts as a negative regulator of T-cell receptor (TCR)-mediated signaling.30
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Third, many of new RA risk loci are also associated with other complex diseases, especially
autoimmune diseases (TNFSF4 with systemic lupus erythematosus (SLE)31,32 and Crohn's
disease33; EOMES with multiple sclerosis34; ETS1 with SLE31,32,35 and celiac disease36;
RAD51B with primary biliary cirrhosis37 and breast cancer38; UBASH3A with type 1
diabetes39,40 and vitiligo41; SYNGR1 with primary biliary cirrhosis22). LBH and UBASH3A
have been suggested as shared risk loci of RA and celiac diseases in a meta-analysis of RA
and celiac datasets,42 but not established in each disease alone. Although functional
connection between the new loci and RA pathogenesis is not elucidated yet, the overlap
suggests a shared etiology across autoimmune diseases.43 All associated genes are known to
be highly expressed in immune cells like T cells or broadly expressed across tissues
including blood cells (online supplementary table S9).
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Fourth, we found evidence that multiple alleles contribute to risk at one of newly discovered
loci. Using a conditional test among individuals of European ancestry, we found that the
lead SNP rs61828284 in 1q25/TNFSF4 could not account for the secondary effect at
rs4090392, nor at the third-effect SNP, rs2027498. Notably, the association of the
secondary-effect SNP but not the third effect SNP became strengthened by conditioning of
the lead SNPs in the meta-analysis. A similar trend was observed among all the Europeanancestry collections. The masked or strengthened significance of the secondary SNP before
or after conditioning may be the result of Simpson’s paradox, which has been shown in a
celiac locus, SOCS1.44
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Finally, we used a trans-ethnic approach to narrow the list of putative causal alleles at each
of the 28 RA risk loci with association signals in both Asians and Europeans. We narrowed
down 563 proxy SNPs (in LD with the lead SNP at r2>0.90 in one or the other population)
to 219 putative causal variants (in LD with the lead SNP in both populations). One example
is shown at the SYNGR1 locus (figure 3). Similarly, the lead SNP at UBASH3A (rs1893592)
among the new loci shared only one proxy SNP in both populations, which is located in 3-bp
downstream of the boundary between exon 10 and intron 10 of UBASH3A. The minor allele
C of rs1893592 disrupts the consensus sequence R (=A or G) of the splice donor site in
contrast to the major allele A, although biological validation is required for the potential
alternative splicing.

Author Manuscript

A limitation of our study is the coverage of the iChip among individuals of Asian ancestry.
The customized iChip array was largely designed to capture variants identified in the CEU
cohort of the 1000 Genomes Project pilot study. As a result, we observe that a large portion
(42%) of the iChip markers were not polymorphic or rare (MAF<0.01) in the Korean
dataset, compare to 22% in the European iChip dataset. Nevertheless, the SNPs with
MAF≥0.01 in the Korean population in the iChip target regions were still dense and almost
overlapped with the SNP with MAF ≥ 0.01 in the European population (online
supplementary figure S2) so that we could perform a high-quality meta-analysis, identify
new RA risk loci, and narrow the list of putative causal variants through a trans-ethnic
approach.
In summary, we identified 8 new RA loci using a dense genetic mapping approach,
providing additional insight into the pathogenesis of RA risk. Fine-mapping and trans-
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ancestral comparison narrowed the list of putative causal variants that may explain the
underlying signal of association at these 8 new loci.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.

Manhattan plot from the meta-analysis of the Korean and European datasets. Newly
identified and known RA risk loci passing the genome-wide significance level (p < 5×10−8)
are shown with the locus names in red and black, respectively. The dashed gray line
indicates the genome-wide significance threshold.
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Figure 2.

Forest plots of the 8 lead SNPs for the 13 independent collections. ORs of the lead SNP in
each RA susceptibility locus (A-H) were shown for each individual collection as well as the
meta-analysis across the sample collections. Locus and SNP name are shown in the top of
each plot. The OR patterns for Korean and European collections are on the blue and pink
background, respectively.
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Figure 3.

Overlap of proxy SNPs shared in the ancestries and regulatory SNPs in the SYNGR1 locus.
(A) Regional association plot for the meta-analysis for the RPL3-SYNGR1 locus in the
chromosome 22. The best hit was found at rs909685 in the intron of SYNGR1. The 13-kb
region containing all proxy SNPs of rs909685 was highlighted with pink. Coordinates are
based on the hg19 assembly. (B) The proxy SNPs (circle) correlated with the lead SNP
rs909685 in Korean and/or European (r2 ≥ 0.9). The two proxy SNPs, rs909685 (red) and
rs2069235 (orange), were observed in both population in contrast to the others (grey). (C)
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The functional annotation of the proxy SNPs. Each proxy SNP was annotated for that it
significantly alters the transcription factor binding motifs by the alleles and that it is in
histone-mark region, DNase-hypersensitive site (DHS), Protein-binding site and eQTL.
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